SUNDAY, SEPTEMBER 25, 2016

Aethlon's Hemopurifier therapy reportedly cures Ebola patient

Hemopurifier therapy reportedly cures Ebola patient. | Contributed photo

Aethlon Medical, a main developer of targeted therapeutic devices for infectious diseases and cancer, diagnosed and cured an Ebola patient using Hemopurifier therapy, a newspaper has reported.

The diagnosis took place at Frankfurt University Hospital. The virus was cured using Aethlon’s new Hemopurifier therapy, a Wall Street Journal story said. The patient was a doctor from Uganda and reportedly is now Ebola-free and fully recovering.

"It is truly wonderful that the patient, who was reported to be suffering from multiple organ failure, is now recovering from Ebola infection," Jim Joyce, the founder and CEO of Aethlon, said. "In the coming days, we will disclose the venue of a public presentation that will report treatment data, including the quantification of viral load reduction and viruses captured by our Hemopurifier during the treatment of this patient."

A bio-filtration device, the Aethlon Hemopurifier rapidly clears the circulation system of viruses and immunosuppressive proteins in infected patients. The treatment is given through dialysis and DRRT machines, which many hospitals and clinics already own.

Concerning Ebola, Hemopurifier eliminates circulating viruses that continue spreading throughout the body and eradicates glycoproteins that deluge the patient’s immune response.

The patient in Germany had to receive special approval to receive Hemopurifier therapy. A branch of the Federal Ministry of Health in Germany, the Federal Institute for Drugs and Medical Devices, approved the treatment.

Up until now, there has been no treatment to cure Ebola patients.

Aethlon intends to begin U.S. clinical studies of the therapy using the U.S. Food and Drug Administration (FDA) standards. The FDA will need to approve Hemopurifier under an Investigational Device Exemption.

Aethlon will use this study to continue development of Hemopurifier as a counteractive measure against diseases such as Ebola, HIV and hepatitis C. The treatment already has helped dozens in India fight HIV and hepatitis C  infections.

Organizations in this story

Aeras 1405 Research Blvd Rockville, MD 20850

U.S. Food and Drug Administration (FDA) 10903 New Hampshire Ave Silver Spring, MD 20903

Get notified the next time we write about any of these organizations!